Navigation Links
New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year

CHAPEL HILL, N.C., Nov. 2 /PRNewswire/ -- Just how much of the time that sales people should be spending with the customer is lost due to administrative tasks and internal communication?

Pharmaceutical sales directors agree the answer is 'too much time' - in fact, 32% of the time used for internal communication - or 6 weeks per rep per year - is unnecessary and causes millions in lost sales every year, according to a recent research study by Best Practices, LLC. But yet, understanding and implementing the key tactics that make a more productive sales force remains a daily challenge.

The report, "Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication," (free report excerpt at: highlights specific practices and performance metrics you can implement today to see immediate results in sales team efficiency and bottom-line revenues.

Findings were collected from surveys and interviews with sales leaders and field sales staff at leading companies, including: Pfizer, Sanofi-Aventis, Purdue Pharma, Janssen, Merck, Eli Lilly, Johnson & Johnson, Ortho-McNeil, Genentech and Allergan.

This report is packed with sales communication metrics and productivity practices. Some of them include:

- Poorly prioritized or redundant communication between pharma sales reps

and their managers causes an estimated $309,000 in annual lost sales

per sales rep.

- Pharma sales reps spend an average of 13.7 hours a week managing

internal communication. Most of this time is spent managing email,

checking voicemail and talking on a cell phone. Of this time, 4.4 hours

(or 32%) are perceived to be unnecessary.

- District managers estimated that they spent 36.5 hours per week

managing internal communication. That's an amazing 1,825 hours per year

per manager.

- Savvy district managers forward emails with a tag in the subject line

that indicates whether the information is "need-to-know" or "nice-to-


- Improve access to online information that can be downloaded and doesn't

need to be delivered through voicemail, email or paper

Download additional sample findings and metrics from the complimentary report excerpt at:

To drill down on the insights presented in this report more deeply contact our Solution Specialists at (919) 403-0251 or

If you have questions about this report or would like to speak to us about how our research can benefit your Sales Force Operations or other initiatives in your company, please contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Today, Mothers ... our nation’s roadways has dropped below 10,000 for the first time since 2011. In ... 2013. , According to data released by the National Highway Traffic Safety Administration (NHTSA), ...
(Date:11/25/2015)... ... 25, 2015 , ... In honor of Pulmonary Hypertension Awareness ... groups responsible for advancing care for pulmonary hypertension (PH) patients and helping to ... will receive special recognition throughout 2016 as part of PHA’s 25th anniversary celebrations. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Many people ... fatigue, fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who find ... diet and exercise regimen instead of their thyroid, especially if they don’t have any ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  The American Academy ... Gynecologists (ACOG), and the March of Dimes cheered ... Protecting Our Infants Act of 2015 (S.799), ... of newborns born exposed to drugs, such as ... bill,s introduction, all three organizations have worked together ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
Breaking Medicine Technology: